Wusson Accelerator AB

Recipharm divests five Swedish plants

Swedish contract manufacturer Recipharm is selling its facilities in Solna, Strängnäs, Höganäs, Karlskoga and Uppsala OTC Development to US private equity compa...

Japansk läkemedelsjätte flyttar till Forskaren

Ännu ett stort läkemedelsbolag flyttar in i Forskaren i Hagastaden.

Speed meets precision for high-density components

ZEISS METROTOM 800 320 kV.

Aurevia

Lonza

Standardisation in automation

B. Braun Melsungen had a great idea and implemented it throughout the plant. Production for infusion solutions was to be largely standardised. B. Braun hoped th...

Oärliga företag tar över vetenskapliga tidskrifter – ”Ett allvarligt hot”

Oseriösa företag som köper upp vetenskapliga tidskrifter och sedan höjer publiceringsavgifterna och börjar masspublicera artiklar är ett växande problem. Läs fö...

She creates pharmaceuticals on a 3D printer

The correct dosage for each individual, regardless of whether the pharmaceutical is for a seriously ill child or a frail elderly person, is the mission of a wel...

The impact of the recession on the Swedish medtech sector

We need health care regardless of whether the economy is good or bad, but the current recession also affects the Medtech sector.

MSD vinner amerikansk rättstvist rörande Gardasil

Läkemedelsbolaget Merck & Co, känt som MSD utanför USA och Kanada, har fått en federal domare i USA på sin sida efter anklagelser om att man skulle ha dolt risk...

New rules for diagnostic products, but who will certify them? “An extreme shortage area”

In less than two weeks, new and stricter EU rules will enter into force for thousands of products used in important diagnoses of, among other things, cancer and...

Bayer has cut 1,500 roles – so far

German chemical and pharmaceutical group Bayer cut more than 1,500 roles in the first quarter alone– and most of them were management positions.

Innovative start-up helps doctors, scientists and industry balance coagulation risks

For many doctors caring for seriously ill patients, for example, in stroke units and cancer wards, maintaining the life-saving balance between bleeding and thro...

Extremely high sample throughput rates

Precision and reliability in automated liquid handling

Astra Zeneca’s Sweden CEO: “We have great faith in our portfolio”

It all started with a summer job as an operator at Astra’s chemical factory in Snäckviken, just outside Södertälje. More than three decades and countless differ...

This years Nobel prize in medicine – “Changed the understanding of how genes are controlled”

This year’s Nobel Prize in Physiology or Medicine goes to the discovery that small RNA molecules, known as microRNAs, control how genes are regulated. Understan...

The fast route to a safe insulin pen

Diabetes is on the rise worldwide with around ten million people developing the disease every year. Demand for insulin pens allowing patients to self-medicate i...

Join the premier metrology and quality assurance event of the year

ZEISS QUALITY INNOVATION SUMMIT in Berlin, October 22-24, 2024.

Studie: Upptäckt om tarmceller ger hopp om att bromsa Crohns sjukdom

Forskare vid Göteborgs universitet har upptäckt ett nytt sätt att angripa Crohns sjukdom. Det handlar om att reparera tarmcellernas skyddsbarriär för att behandla sjukdomen.

Jan Holmgren to receive award for the development of cholera vaccine

Researcher Jan Holmgren is being awarded for the development of the first effective drinkable cholera vaccine. The award is given by the International Vaccine I...

Integrated solutions for liquid handling

Greater efficiency for manufacturers in laboratory automation and many other industries

Controlled Pneumatics: pushing the boundaries of pneumatics

automation processes that are already known. It also opens up new opportunities, especially for controlling pressure and flow rate. Piezo valves, which enable v...

Individual DNA passport could result in fewer drug side effects

You may be required to show a DNA passport when you pick up medicines at the pharmacy in the future. According to a new study, patients might suffer 30% fewer side effects if the drug treatment is adapted to their genes....